top of page
Search
Catie Barrett
Aug 31, 20232 min read
Biosynth Offers Novel Human Hybrid IgM Monoclonal Antibodies to Replace Natural Disease State Plasma
Dublin, Ireland, 31st August 2023 – Biosynth Ltd, is delighted to offer the following innovative range of novel Human Hybrid IgM...
130 views0 comments
Claire Duffy
Aug 1, 20232 min read
Rebrand of Aalto Bio Reagents and Fitzgerald Industries International to Biosynth
We have collected some of the frequently asked questions related to our rebrand on August 1st, 2023, to ensure a smooth transition. For...
192 views0 comments
Catie Barrett
Jun 16, 20232 min read
Aalto Bio Reagents Launches Antibody to Cholera Toxin B Amidst Cholera Outbreak and Vaccine Shortage
Dublin, Ireland – 30th May 2023 - Aalto Bio Reagents, has recently launched their new Mouse Monoclonal Antibody (MAb) to Cholera Toxin B...
142 views0 comments
Rachel O'Reilly
Oct 10, 20222 min read
Aalto Bio Reagents Launches New Monkeypox Virus B21R-BSA Conjugate Peptides for Diagnostic Testing
Dublin, Ireland – 10th October 2022 - Aalto Bio Reagents Ltd., a leading global supplier of critical raw materials to the in-vitro...
201 views0 comments
bottom of page